The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy

NCT00666536 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

728

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: valsartan and amlodipine
DRUG: valsartan and amlodipine

Sponsor

Novartis